DALLAS, March 22, 2019 — via OTC PR WIRE — North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today published an update on. Source: Kaly USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY Kaly
Read MoreCategory: MARIJUANA STOCKS
KALY Publishes Cannabis Extract COPD Treatment Study Report
DALLAS, Feb. 05, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today published a preview of the recently announced long-term, pilot study on the treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates with cannabis extracts derived from Kali-Extracts patented cannabis extraction process. The study adds to the Kali-Extracts in…
Read MoreKALY Confirms Pharmaceutical Cannabis Extract Report On Recent Trials Scheduled For Tomorrow
DALLAS, March 21, 2019 (GLOBE NEWSWIRE) — — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates. The primate study adds to the Kali-Extracts in vitro genomics study, previously announced, to evaluate…
Read MoreKALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019
DALLAS, March 20, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company plans to publish its phase one research on the pilot treatment of Chronic Obstructive Pulmonary Disease (COPD) in primates. The research paper comes from Professor Jeffry Osbourn, Ph.D., from the University of Kentucky and the…
Read MoreKALY Initiates Phase Two Cannabis Extract COPD Treatment Study
DALLAS, March 18, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced Professor Jeffry Osbourn, Ph.D., from the University of Kentucky and the principal of Biomedical Science Research Group (BSRG), and KALY CEO Frederick Ferri met last week to coordinate a phase two study of a pilot treatment of…
Read MoreCaptor Capital Announces Commencement of Trading on OTCQX® Best Market
TORONTO, March 18, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (“Captor” or the “Company”) (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; OTCQX: CPTRF), a cannabis-focused investment company, is pleased to announce it has qualified for trading on the OTCQX® Best Market (“OTCQX”). Captor Capital upgraded to OTCQX from the Pink® market. The OTCQX Market is reserved for established, investor-focused U.S. and…
Read MoreThis Tiny Marijuana Stock Is a Better Bet Than Tilray (NASDAQ:TLRY) or Canopy Growth (TSX:WEED)
Marijuana stocks have been on fire for much of the past year. In the run up to legalization, many of them climbed to eye-watering valuations from relative obscurity. If you’re looking to invest in a weed stock now, you’re probably a bit late. The undeniable leader in this space is still Ontario-based Canopy Growth (TSX:WEED)(NYSE:CGC). South of the border, Tilray…
Read MoreWill Amazon (NASDAQ:AMZN) Get Involved in Cannabis?
Over the past few years, there’s been a lot of interest in cannabis from other industries. While most of it has been just tire kicking, there have been a couple of big deals, most notably involving Constellation Brands and Canopy Growth. However, cannabis isn’t a fit for everyone, at least not while cannabis remains illegal federally. Starbucks suggested that it might not be a…
Read MoreHas Canopy Growth Corp (TSX:WEED) Peaked?
Canopy Growth (TSX:WEED)(NYSE:CGC) struggled late in 2018, as its shares went into a tailspin to close out the year. And although it has recovered in the new year, there are signs that the rally may be over already. Year to date, Canopy Growth is up more than 65%, but those gains came in January; since the start of February, the…
Read MoreIs Canopy Growth Corp (TSX:WEED) or Toronto-Dominion Bank (TSX:TD) Stock a Buy for Your TFSA Today?
Canadian investors are trying to decide which stocks will drive the best returns in their self-directed TFSA portfolios. Let’s take a look at Canopy Growth (TSX:WEED)(NYSE:CGC) and TD Bank (TSX:TD) (NYSE:TD) to see if one is an attractive choice right now. Canopy Growth The emergence of marijuana stocks from penny-stock status to TSX Index members in a very short time…
Read More